Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Investments in Legislative Advocacy Pay Off for Ohio Association of Rheumatology

Gretchen Henkel  |  August 14, 2017

Annual Meeting Additions

OAR and ACR Advocacy Updates will be presented when the 12th Annual Meeting of the OAR convenes Aug. 25 at the Greater Columbus Convention Center. Two of the key scientific sessions feature Michelle Petri, MD, MPH, professor of medicine and director of the Lupus Center at The Johns Hopkins University’s School of Medicine, who will present an update on SLE and discuss new developments regarding antiphospholipid syndrome. This year’s meeting will also add a new breakout session on practice management and a poster presentation section for fellows.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Steps for Effective Advocacy

Having worked with state legislators, Dr. Ott furnished some advice to other state rheumatology associations that may be contemplating similar actions:

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  • Know your audience: legislators may not have been medical professionals, so furnish good handouts that clearly explain the issues and problems.
  • Limit your talking points: “At the most, you will have 15–20 minutes with the representative.”
  • Hone your message: “Explain your message as you would to a family member,” Dr. Ott counsels. “Partner with the Arthritis Foundation or include a patient who can present a personal story in a succinct way.”
  • Reach out to the ACR: “If you’re not sure how to effectively advocate, the ACR is more than willing to help you learn these skills.” Dr. Ott suggests contacting the ACR’s Affiliate Society Council, the Insurance Subcommittee or the Government Affairs Committee. Visit the ACR’s Legislative Action Center.
  • Finally, Dr. Ott offers her colleagues the opportunity to reach out to her. “I’m always willing to answer questions to help another state or another person do this,” she says.
  • “I’m a big believer [in the idea] that if we want to really focus on the practice of rheumatology, where we can just take care of patients in the way we feel is best, then we also have to focus on all of the policies that affect that.”

Gretchen Henkel is a medical journalist based in California.

Reference

  1. Omair MA, Alahmadi A, Johnson SR. Safety and effectiveness of mycophenolate in systemic sclerosis. A systematic review. PLoS One. 2015 May 1;10(5):e0124205. doi: 10.1371/journal.pone.0124205. eCollection 2015.

Page: 1 2 | Single Page
Share: 

Filed under:Legislation & Advocacy Tagged with:Ohio Association of Rheumatology (OAR)step therapy

Related Articles

    Ohio Rheumatologists Advocate for Step Therapy Reform & More

    April 19, 2017

    On a chilly March morning in Lancaster, Ohio, rheumatologist Stephanie Ott, MD, shared the Ohio Association of Rheumatology’s (OAR) current advocacy efforts with ACR@Work between walking her three dogs and driving to her clinic to see patients—some of whom travel from as far away as West Virginia. “This year, we are really focusing on legislation…

    RheumPAC Advocacy Fund: Effecting Change

    September 16, 2021

    Professional practices, state societies and other organizations can support RheumPAC’s work with corporate funds through the RheumPAC Advocacy Fund.

    4 ARP Members Talk About Their Roads to Advocacy & Why It Matters

    May 13, 2021

    The Budget Control Act of 2011 cut Medicare physician payments by 2% across the board. The Coronavirus Aid, Relief, and Economic Security (CARES) Act, signed into law in 2020, suspended this sequester (i.e., a cut in government spending) between May 1 and Dec. 31, 2020. In the Consolidated Appropriations Act, signed into law in December…

    Supporting Women in Rheumatology

    September 6, 2021

    In 2014, four rheumatologists formed a new organization to promote gender equity within the field. Today, the Association of Women in Rheumatology offers training and opportunities in leadership, business development, financial planning and more, as recently highlighted at its annual meeting Aug. 12–15.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences